Comprehensive Parkinson's Disease Treatment Strategies: A Multifaceted Approach to Target Key Molecular Players
Explore cutting-edge therapeutic strategies for Parkinson's disease, focusing on α-synuclein, LRRK2, Parkin, PINK1, and GBA.
- Perform high-throughput screening of chemical libraries to identify potential α-syn aggregation inhibitors.
- Use computational methods, such as molecular docking, to predict the binding mode of candidate inhibitors.